BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9690616)

  • 1. A comparison of edrophonium and neostigmine for the reversal of mivacurium-induced neuromuscular blockade in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):265-6. PubMed ID: 9690616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
    Fleming NW; Lewis BK
    Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium.
    Szenohradszky J; Fogarty D; Kirkegaard-Nielsen H; Brown R; Sharma ML; Fisher DM
    Anesthesiology; 2000 Mar; 92(3):708-14. PubMed ID: 10719950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium.
    Devcic A; Munshi CA; Gandhi SK; Kampine JP
    Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the neuromuscular and cardiovascular effects of vecuronium, atracurium and mivacurium in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):233-7. PubMed ID: 9690609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of mivacurium-induced neuromuscular blockade with a cholinesterase inhibitor: A systematic review.
    Brinch JHW; Söderström CM; Gätke MR; Madsen MV
    Acta Anaesthesiol Scand; 2019 May; 63(5):564-575. PubMed ID: 30548256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and autonomic nervous effects of edrophonium and atropine combinations during neuromuscular blockade antagonism in sheep.
    Clutton RE; Glasby MA
    Vet Anaesth Analg; 2008 May; 35(3):191-200. PubMed ID: 18282258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion.
    Maddineni VR; Mirakhur RK; McCoy EP
    Anaesthesia; 1994 Nov; 49(11):946-8. PubMed ID: 7802237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of different doses of edrophonium antagonism of mivacurium-induced neuromuscular block in the presence of nitrous oxide, propofol, and alfentanil anesthesia].
    Ripart J; Drolet P; Perreault L; Girard M
    Can J Anaesth; 1996 Apr; 43(4):368-72. PubMed ID: 8697552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Samarkandi AH; Bakhamees HS; Turkistani A; Alharby SW
    Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.